Double maintains 4 strategies that include CORT - Corcept Therapeutics, Inc.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FLMX | 0.08% | $56.35M | 0.19% |
| STOT | -0.14% | $252.82M | 0.45% |
| AGZD | 0.24% | $98.56M | 0.23% |
| IBTI | -0.29% | $1.06B | 0.07% |
| UNG | -0.30% | $375.27M | 1.06% |
| EWW | 0.40% | $1.85B | 0.5% |
| BWX | -0.47% | $1.53B | 0.35% |
| SHYM | -0.54% | $355.86M | 0.35% |
| SCHO | -0.58% | $10.98B | 0.03% |
| IBTG | 0.61% | $1.92B | 0.07% |
| SPTS | -0.65% | $5.77B | 0.03% |
| ARGT | 0.66% | $1.02B | 0.59% |
| UTWO | -0.70% | $376.33M | 0.15% |
| NEAR | 0.73% | $3.35B | 0.25% |
| EWQ | 0.89% | $432.30M | 0.5% |
| REMX | 1.05% | $323.75M | 0.58% |
| BSCQ | 1.05% | $4.25B | 0.1% |
| PFFR | -1.05% | $94.76M | 0.45% |
| FXB | -1.06% | $91.13M | 0.4% |
| ASHR | 1.26% | $1.93B | 0.65% |
SeekingAlpha
ClearBridge Global Value Improvers Strategy Q2 2025 Commentary
Yahoo
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Yahoo
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 2, Corcept Therapeutics Incorporated (NASDAQ:CORT) announced pivotal data from its Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the American Society of Clinical Oncology Annual Meeting. According […]
Yahoo
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best NASDAQ growth stocks to buy for the next 3 years. On June 24, Corcept Therapeutics announced positive results from the CATALYST trial of Korlym (mifepristone). The data was presented at the American Diabetes Association’s 85th Scientific Sessions and also published in Diabetes Care. It showed that […]
Yahoo
Corcept Therapeutics (NasdaqCM:CORT) recently saw a decline in its share price by 1.43% over the last week. This price movement occurred against a backdrop of the company's removal from the Russell 2000 and Russell 2000 Growth indices, while simultaneously gaining inclusion in several other indices, like the Russell 1000 and Russell Midcap Growth Index. These index changes suggest shifts in investment positioning that could impact market sentiment. Amidst these developments, the overall...
Finnhub
Corcept Therapeutics Incorporated added to Russell Midcap Growth Index...
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -15.23% | $184.73M | 0.85% |
| TAIL | -13.30% | $94.86M | 0.59% |
| TPMN | -11.97% | $31.06M | 0.65% |
| BTAL | -10.54% | $315.93M | 1.43% |
| SGOV | -9.29% | $50.93B | 0.09% |
| BILZ | -9.00% | $851.85M | 0.14% |
| IVOL | -8.36% | $342.69M | 1.02% |
| FTSD | -8.22% | $233.11M | 0.25% |
| BIL | -8.07% | $41.93B | 0.1356% |
| FXC | -7.92% | $92.85M | 0.4% |
| YEAR | -7.21% | $1.46B | 0.25% |
| XBIL | -6.40% | $784.60M | 0.15% |
| XONE | -6.29% | $628.85M | 0.03% |
| FXE | -6.11% | $588.06M | 0.4% |
| GSST | -6.03% | $920.88M | 0.16% |
| IBTH | -5.61% | $1.62B | 0.07% |
| IBMO | -5.40% | $527.22M | 0.18% |
| XHLF | -4.97% | $1.73B | 0.03% |
| GREK | -4.88% | $298.80M | 0.57% |
| UDN | -4.71% | $147.46M | 0.78% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DHT | 0.01% | $1.77B | +1.75% | 7.32% |
| CMPS | 0.01% | $345.40M | -48.48% | 0.00% |
| BSAC | 0.03% | $11.54B | +19.76% | 5.47% |
| MIST | 0.03% | $136.87M | +69.54% | 0.00% |
| CSAN | 0.04% | $2.18B | -55.39% | 0.00% |
| CVGW | -0.04% | $488.20M | +24.75% | 2.94% |
| IRS | 0.05% | $1.10B | +61.08% | 7.09% |
| DVAX | -0.06% | $1.31B | +3.71% | 0.00% |
| ULCC | 0.08% | $993.06M | +0.93% | 0.00% |
| NFE | 0.09% | $965.18M | -82.90% | 0.00% |
| SUPV | 0.09% | $822.36M | +61.40% | 1.98% |
| RILY | -0.09% | $135.71M | -74.74% | 0.00% |
| COGT | 0.10% | $1.24B | +18.71% | 0.00% |
| IE | 0.11% | $1.36B | -1.54% | 0.00% |
| SYRE | -0.12% | $963.24M | -43.26% | 0.00% |
| PRO | -0.12% | $778.56M | -35.51% | 0.00% |
| CGEM | -0.14% | $462.68M | -51.55% | 0.00% |
| MRNA | -0.14% | $13.26B | -72.09% | 0.00% |
| ASPS | -0.16% | $152.11M | +47.41% | 0.00% |
| TRUG | -0.16% | $5.41M | -89.51% | 0.00% |
Current Value
$72.011 Year Return
Current Value
$72.011 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PCVX | -40.81% | $4.68B | -55.78% | 0.00% |
| GORV | -17.22% | $26.23M | -91.97% | 0.00% |
| IIPR | -16.71% | $1.57B | -51.17% | 13.65% |
| TLPH | -15.37% | $10.48M | -43.30% | 0.00% |
| XBIO | -15.25% | $5.91M | -5.85% | 0.00% |
| XOS | -14.02% | $28.34M | -48.25% | 0.00% |
| TRVG | -12.92% | $83.97M | +73.93% | 0.00% |
| GALT | -12.85% | $155.06M | +3.81% | 0.00% |
| CREG | -12.32% | $5.91M | -76.05% | 0.00% |
| XP | -11.21% | $9.81B | +1.53% | 0.00% |
| ORKA | -10.10% | $526.79M | -34.33% | 0.00% |
| FF | -8.56% | $180.03M | -21.11% | 5.79% |
| VHC | -8.41% | $69.05M | +176.10% | 0.00% |
| APLS | -8.33% | $2.45B | -49.78% | 0.00% |
| CATO | -8.16% | $60.00M | -43.60% | 5.59% |
| MVO | -7.91% | $69.00M | -38.46% | 20.74% |
| RKT | -7.54% | $2.09B | +2.91% | 0.00% |
| SSRM | -7.26% | $2.52B | +143.05% | 0.00% |
| IFRX | -7.06% | $60.10M | -45.41% | 0.00% |
| LXRX | -6.96% | $410.39M | -39.25% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PSQA | 51.95% | $36.49M | 0.2% |
| XPH | 37.34% | $150.58M | 0.35% |
| FBT | 34.55% | $1.02B | 0.54% |
| IHE | 31.29% | $551.02M | 0.39% |
| XSMO | 29.83% | $1.73B | 0.39% |
| PTH | 26.88% | $96.25M | 0.6% |
| QMOM | 26.79% | $351.29M | 0.29% |
| MGV | 24.99% | $9.60B | 0.07% |
| PVAL | 24.60% | $3.55B | 0.56% |
| VTV | 24.39% | $139.95B | 0.04% |
| FTLS | 24.35% | $2.00B | 1.38% |
| VYM | 23.97% | $61.73B | 0.06% |
| NULV | 23.96% | $1.74B | 0.26% |
| IWX | 23.81% | $2.76B | 0.2% |
| DHS | 23.72% | $1.25B | 0.38% |
| OUSA | 23.69% | $817.37M | 0.48% |
| DLN | 23.68% | $5.07B | 0.28% |
| PBJ | 23.66% | $97.96M | 0.62% |
| IWD | 23.58% | $62.61B | 0.19% |
| DIVB | 23.50% | $946.50M | 0.05% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HMST | 49.19% | $251.65M | +6.31% | 0.00% |
| COOP | 41.48% | $9.49B | +76.30% | 0.00% |
| VRRM | 39.54% | $4.05B | -11.59% | 0.00% |
| UMC | 32.98% | $18.99B | -8.47% | 6.32% |
| OMC | 26.92% | $14.33B | -20.42% | 3.84% |
| NWSA | 26.81% | $16.79B | +6.54% | 0.67% |
| LITB | 26.23% | $24.26M | -71.62% | 0.00% |
| LYV | 26.00% | $33.48B | +50.67% | 0.00% |
| FOX | 25.81% | $23.34B | +56.09% | 1.03% |
| NWS | 25.81% | $19.50B | +20.29% | 0.58% |
| IPG | 25.47% | $9.24B | -13.46% | 5.32% |
| STHO | 25.06% | $109.22M | -34.35% | 0.00% |
| RITM | 24.97% | $6.23B | +6.33% | 8.54% |
| SHW | 24.65% | $88.17B | +12.06% | 0.87% |
| BXMT | 23.56% | $3.45B | +6.12% | 9.42% |
| ECG | 23.49% | $3.43B | +37.43% | 0.00% |
| WMT | 23.35% | $757.02B | +35.90% | 0.93% |
| V | 23.10% | $690.11B | +35.55% | 0.65% |
| NLY | 23.06% | $11.99B | -0.60% | 13.70% |
| TJX | 23.00% | $138.52B | +8.97% | 1.25% |
